Treatment sequences and outcomes of patients with CLL treated with venetoclax and other novel agents post introduction of novel therapies Meeting Abstract
| Authors: | Mato, A. R.; Sail, K.; Yazdy, M. S.; Hill, B. T.; Shadman, M.; Manzoor, B. S.; Tuncer, H. H.; Allan, J. N.; Ujjani, C. S.; Sharmokh, S.; Jiang, D. D.; Pena, G.; Marshall, T.; Nielsen, J.; Barr, P. M.; Brown, J. R.; Schuh, A.; Eyre, T. A.; Wierda, W. G.; Skarbnik, A.; Roeker, L. E.; Bannerji, R.; Pauff, J. M.; Schuster, S. J.; Follows, G. A.; Cheson, B. D.; Eichhorst, B. F.; Brander, D. M.; Pivneva, I.; Lamanna, N. |
| Abstract Title: | Treatment sequences and outcomes of patients with CLL treated with venetoclax and other novel agents post introduction of novel therapies |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160403028 |
| DOI: | 10.1182/blood-2019-124600 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1756 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work